Journal of Clinical Oncology | 2024
Minimal Residual Disease Status in Multiple Myeloma 1 year after autologous hematopoietic cell transplantation and lenalidomide maintenance are associated with long-term overall survival.
Pasquini M, Wallace PK, Logan B, Kaur M, Tario JD, Howard A, Zhang Y, Brunstein C, Efebera Y, Geller N, Giralt S, Hari P, Horowitz MM, Koreth J, Krishnan A, Landau H, Somlo G, Shah N, Stadtmauer E, Vogl DT, Vesole DH, McCarthy PL, Hahn T
PubMed
PMID: 38701390
Abstract
Related Articles
CIBMTR Study #: 0702